Results of a phase II trial with second-line cystemustine at 60mg/m 2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group

By Cure H.   Krakowski I.   Adenis A.   Tubiana N.   Kerbrat P.   Roche H.   Chevallier   Lentz M.A.   Fumoleau P.   Chollet P.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 422-423

Elsevier

Access to resources Recommend Favorite

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

By van Wijk F.H.   Lhomme C.   Bolis G.   Scotto di Palumbo V.   Tumolo S.   Nooij M.   de Oliveira C.F.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 78-85

Elsevier

Access to resources Recommend Favorite

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

By Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

By Lhomme C.   Vermorken J.B.   Mickiewicz E.   Chevalier B.   Alvarez A.   Mendiola C.   Pawinski A.   Lentz M.A.   Pecorelli S.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 194-199

Elsevier

Access to resources Recommend Favorite

Phase II trial with S-1 in chemotherapy-nave patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG)

By Chollet P.   Schoffski P.   Weigang-Kohler K.   Schellens J.H.M.   Cure H.   Pavlidis N.   Grunwald V.   De Boer R.   Wanders J.   Fumoleau P.  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1264-1270

Elsevier

Access to resources Recommend Favorite